期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胃癌组织TGF-β1、TGF-βRⅡ、p27^(kipl)的表达水平及临床意义

The Expressions and Prognostic Significance of TGF-β1 and TGF-βR II and p27^(Kip1) in the Gastric Carcinoma
下载PDF
导出
摘要 目的探讨胃癌组织TGF-βRⅡ及p27kipl表达水平与临床病理因素间的关系。方法采用免疫组化EnVision二步法对胃癌组织、切端胃粘膜组织进行GF-βRⅡ及p27kipl染色,图像分析系统测定癌组织、邻癌粘膜组织及切端粘膜组织的实质细胞数和阳性细胞数,计算阳性细胞比率。结果癌组织TGF-β1表达水平高于切端粘膜组织,p27kipl及GF-βRⅡ的表达水平低于切端粘膜组织。p27kipl与GF-βRⅡ两者间表达水平呈正相关。p27kipl表达水平与肿瘤的分化程度、浸润深度及淋巴结转移相关GF-βRⅡ表达水平与肿瘤的浸润深度相关。结论胃癌组织TGF-βRⅡ、p27kipl表达显著降低,并与胃癌的一些临床病理因素相关;TGF-β1表达增高并可能通过GF-βRⅡ、p27kipl等对肿瘤的生物学行为产生影响,对相邻上皮细胞的恶性转化可能也有促进作用。 Objective To investigate the expression level and their prognostic significance of TGF-β1, TGF-βRII and p27^kipl were detected by using two-step Methods of EnVision immunohistochemical system. And image analysis was employed to measure the number of parenchyma cells and the positive cells, and to calculate the positive ratio respectively. Results Compared with those in distant normal mucosa, the expression levels of TGF-βRII and p27^Kipl decreased in the tumor tissue and the adjacent mucosa, while that of TGF-β1 increased. The expression of p27^kipl correlated positively with that of TGF-βRIL Conclusion The expression levels of TGF-βR II and p27^kipl decrease obviously in the tumor tissue, and is related with some clinicopathological features. The over expression of TGF- β1 take the influence possibly to the tumor biology behavior through TGF-βRII and p27^Kipl, and may be promote malignancy transform also of the adjacent epithelial cell.
作者 万昌武 胡军 刘启兰
机构地区 贵阳医学院病理学教研室
出处 《贵州医药》 CAS 2008年第4期299-301,共3页 Guizhou Medical Journal
关键词 胃癌 转化生长因子-Β1 转化生长因子受体Ⅱ P27^KIPL 免疫组织化学 Gastric carcinoma TGF-β1 TGF-βR II p27^Kipl Immunohistochemistry
分类号 R730.2 [医药卫生—肿瘤]
  • 相关文献

参考文献12

  • 1von Rahden BH, Stein HJ, Feith M, et al. Overexpression of TCF-betal in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis[J]. Mol Carcinog, 2006, 45 (10) : 786-794.
  • 2Shariat SF, Menesses-Diaz A, Kim IY, et al, Tissue expression of transforming growth factor-betal and its receptors:correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy[J]. Urology,2004,63(6): 1 191-1 197.
  • 3Xu Q, Wang S, Xi L, et al. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and irnmuno-escape through the TGFbetal signaling pathway[J]. Gynecol Oncol,2006,101 (1) : 132-139.
  • 4Lee C, Sintich SM, Mathews EP, et al. Transforming growth factor-beta in benign and malignant prostate [J]. Prostate, 1999,39(4) :285-290.
  • 5Santibanez JF. JNK mediates TGF-betal-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes[J]. FEBS Lett, 2006, 580 (22):5 385-5 391.
  • 6GotzmarmJ, Huber H, Thallinger C, et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-betal and Ha-Ras: steps towards invasiveness[J]. J Cell Sci, 2002, 115(Pt 6): 1 189- 1 202.
  • 7Lee BS, Nowak RA. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta[J]. J Clin Endocrinol Metab,2001,86(2) :913-920.
  • 8Lecanda J, Parekh TV, Gama P, et al. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27^kipl in the normal and malignant endometrium [J]. Cancer Res, 2007, 67 (3) : 1 007-1 018.
  • 9McGarvey TW, Tait E, Tomaszewski JE, et al. Expression of Transforming Growth Factor-beta Receptors and Related Cell-Cycle Components in Transition- al-Cell Carcinoma of the Bladder[J]. Mol Urol, 1999, 3(4) : 371-380.
  • 10Kawagnchi K, Oda Y, Saito T, et al. Decreased expression of transforming growth factor-beta Ⅱ receptor is associated with that of p27^kipt in giant cell tumor of bone: a possible link between transforming growth factor-beta and cell cycle-related protein [J]. Hum Pathol, 2004, (1) :61-68.

二级参考文献11

  • 1Maeda K, Chung YS, Onoda N, et al. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis [J]. Cancer, 1994,73(3):528～533.
  • 2Shimizu M, Saitoh Y, Itoh H, et al. Immunohistochemical staining of H-ras oncogene product in normal, benign and malignant human pancreatic tissue[J]. Hum Pathol, 1990, 21:607.
  • 3Noda H, Maehara Y, Irie K, et al. Increased proliferative activity caused by loss of p21 (WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinoma[J]. Cancer,2002, 94(7):2107～2112.
  • 4Mori M, Kakeji Y, Adachi Y, et al. The prognostic significance of proliferating cell nuclear antigen in clinacal gastric cancer [J].Surgery, 1993, 113(6):683～690.
  • 5Aoyagi K, Kohfuji K, Yano S, et al. Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreadingtype and penetrating-type gastric carcinoma [J]. Kurume Med J,2001, 48(3):197～200.
  • 6Garcia I, Vizoso F, Andicoechea A, et al. Clinical significance of epidermal growth factor receptor content in gastric cancer[J]. Int J Biol Markers, 2001, 16(3):183～188.
  • 7Koullias GJ, Kouraklis GP, Raftopoulos IS, et al. Increased estrogen receptor and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas [J]. J Surg Oncol, 1996, 63(3):166～171.
  • 8Hirono Y, Tsugawa K, Fushida S, et al. Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer[J]. Oncology, 1995, 52 (3):182～188.
  • 9Boivin GP, Molina JR, Ormsby I, et al. lesions in transfroming growth factor beta-1 heterozygous mice [J]. Lab Invest,1996, 74(2):513～518.
  • 10Takeno S, Wirtz HC, Lickvers K,et al. Transforming growth factor beta type Ⅱ receptor expression in gastric cancer: evidence for two independent subgroups[J]. Anticancer Res, 2002, 22(4):2247～2252.

共引文献18

贵州医药
2008年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部